SCHEMBL7520863

SCHEMBL7520863

CCCNc1ccccc1S(=O)(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.50
IDO1 P14902 1/20 0.45
CA12 O43570 5/20 0.44
CA9 Q16790 5/20 0.44
CA1 P00915 3/20 0.44
CA2 P00918 3/20 0.44
TTR P02766 1/20 0.41
FABP4 P15090 1/20 0.41
CCNA2 P20248 1/20 0.41
CDK2 P24941 1/20 0.41
MAPK14 Q16539 1/20 0.41
NR4A1 P22736 1/20 0.40
RECQL P46063 1/20 0.40
ADRA2C P18825 2/20 0.39
ADRA1D P25100 2/20 0.39
ADRA1A P35348 2/20 0.39
ADRA1B P35368 2/20 0.39
HSD17B10 Q99714 1/20 0.39
MYC P01106 1/20 0.39
CISD1 Q9NZ45 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7514004 0.90 L3MBTL1 (0.58) L3MBTL1CA12CA9CA1CA2
SCHEMBL27278463 0.90 L3MBTL1 (0.62) L3MBTL1CA12CA9CA1CA2
SCHEMBL31299788 0.88 L3MBTL1 (0.64) L3MBTL1CA12CA9RECQLCISD1
SCHEMBL4726651 0.85 TTR (0.42) L3MBTL1IDO1CA12CA9CA1
SCHEMBL27619929 0.84 L3MBTL1 (0.56) L3MBTL1CA12CA9CA1CA2
SCHEMBL11139997 0.84 KDM4E (0.47) L3MBTL1CA12CA9CA1CA2
SCHEMBL7354878 0.82 CA2 (0.59) L3MBTL1IDO1CA12CA9CA1
SCHEMBL8077342 0.80 CA1 (0.44) L3MBTL1CA12CA9CA1CA2
SCHEMBL13588758 0.79 ADRA1D (0.52) L3MBTL1IDO1CA12CA9CA1
SCHEMBL11574103 0.79 IDO1 (0.45) L3MBTL1IDO1CA12CA9CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4729582-A1 WATER SOLUBLE COMPOSITION, METHOD FOR PRODUCING SAME, CONDUCTIVE COMPOSITION, AND METHOD FOR PRODUCING SAME Mitsubishi Chemical Corporation (JP) 2026-04-22 EP disclosed
US-20260098127-A1 WATER SOLUBLE COMPOSITION, METHOD FOR PRODUCING SAME, CONDUCTIVE COMPOSITION, AND METHOD FOR PRODUCING SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2026-04-09 US disclosed
US-12443103-B2 Conductive composition and method for manufacturing same, and conductor and method for manufacturing same MITSUBISHI CHEMICAL CORPORATION (JP) 2025-10-14 US disclosed
EP-4588657-A1 MANUFACTURING METHOD FOR CONDUCTIVE FILM, MANUFACTURING METHOD FOR MASK, MANUFACTURING METHOD FOR SEMICONDUCTOR DEVICE, DEFECT EXAMINATION METHOD FOR CONDUCTIVE FILM, AND DEFECT EXAMINATION DEVICE Mitsubishi Chemical Corporation (JP) 2025-07-23 EP disclosed
US-20250208500-A1 MANUFACTURING METHOD FOR CONDUCTIVE FILM, MANUFACTURING METHOD FOR MASK, MANUFACTURING METHOD FOR SEMICONDUCTOR DEVICE, DEFECT EXAMINATION METHOD FOR CONDUCTIVE FILM, AND DEFECT EXAMINATION DEVICE MITSUBISHI CHEMICAL CORPORATION (JP) 2025-06-26 US disclosed
CN-119836599-A Method for manufacturing conductive film, method for manufacturing mask, method for manufacturing semiconductor device, method for inspecting defect of conductive film, and defect inspection apparatus 三菱化学株式会社 2025-04-15 CN disclosed
WO-2024257864-A1 WATER SOLUBLE COMPOSITION, METHOD FOR PRODUCING SAME, CONDUCTIVE COMPOSITION, AND METHOD FOR PRODUCING SAME 三菱ケミカル株式会社 2024-12-19 WO disclosed
US-20240371542-A1 CONDUCTOR, CONDUCTIVE COMPOSITION AND LAMINATE MITSUBISHI CHEMICAL CORPORATION (JP) 2024-11-07 US disclosed
EP-3709081-B1 CONDUCTIVE POLYMER COMPOSITION, COATED PRODUCT AND PATTERNING PROCESS SHINETSU CHEMICAL CO (JP) 2024-09-18 EP disclosed
CN-118620412-A Conductive composition, resist coating material, resist, and method for forming resist pattern 三菱化学株式会社 2024-09-10 CN disclosed
EP-2551290-A1 CONDUCTIVE POLYMER, QUALITY CONTROL METHOD FOR CONDUCTIVE POLYMER AND METHOD FOR PURIFYING CONDUCTIVE POLYMER Mitsubishi Rayon Co., Ltd. (JP) 2013-01-30 EP disclosed
US-20130012655-A1 CONDUCTIVE POLYMER, QUALITY CONTROL METHOD FOR CONDUCTIVE POLYMER AND METHOD FOR PURIFYING CONDUCTIVE POLYMER TECHNICAL FIELD MITSUBISHI RAYON CO., LTD. (JP) 2013-01-10 US disclosed
EP-0662694-B1 Soluble aniline conducting polymers MITSUBISHI RAYON CO (JP) 2002-02-27 EP disclosed
EP-0834885-B1 Method for producing soluble conductive polymers having acidic groups MITSUBISHI RAYON CO (JP) 2002-01-02 EP disclosed
US-5980784-A SUBJECTING TO ELECTROLYTIC POLYMERIZATION AT LEAST ONE COMPOUND SELECTED FROM THE GROUP CONSISTING OF ACIDIC GROUP SUBSTITUTED ANILINES, PYRROLES, THIOPHENES, FURANS, SELENOPHENES, TELLUROPHENES, ISOTHIANAPHTHENES, IN BASE MITSUBISHI RAYON CO., LTD. (JP) 1999-11-09 US disclosed
US-5932144-A ALKOXY GROUP SUBSTITUTED AMINOBENZENESULFONIC ACID, OR SALT THEREOF MITSUBISHI RAYON CO., LTD. (JP) 1999-08-03 US disclosed
EP-0834885-A2 Method for producing soluble conductive polymer having acidic groups NITTO CHEMICAL INDUSTRY CO., LTD. (JP) 1998-04-08 EP disclosed
US-5700399-A Soluble alkoxy-group substituted aminobenzenesulfonic acid aniline conducting polymers NITTO CHEMICAL INDUSTRY CO., LTD. (JP) 1997-12-23 US disclosed
US-5589108-A Soluble alkoxy-group substituted aminobenzenesulfonic acid aniline conducting polymers NITTO CHEMICAL INDUSTRY CO., LTD. (JP) 1996-12-31 US disclosed
EP-0662694-A2 Soluble aniline conducting polymers NITTO CHEMICAL INDUSTRY CO., LTD. (JP) 1995-07-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260098127-A1 WATER SOLUBLE COMPOSITION, METHOD FOR PRODUCING SAME, CONDUCTIVE COMPOSITION, AND METHOD FOR PRODUCING SAME GJA1, GUCY1A2, GJB2 L3MBTL1 3666/4885IDO1 3152/4885CA12 378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.